- CEO
- Ka Chun Wong
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 37 Greenbriar Drive Summit NJ United States of America 07901
- IPO Date
- Jul 25, 2023
- Business
- Keen Vision Acquisition Corporation (KVACU) operates as a blank check company, or special purpose acquisition company (SPAC), incorporated in the British Virgin Islands in 2021 and headquartered at 37 Greenbriar Drive, Summit, New Jersey; the company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses, primarily targeting opportunities in the biotechnology, consumer goods, and agriculture sectors evaluated on sustainability and environmental, social, and governance (ESG) criteria, with an enterprise value not exceeding $1 billion. KVACU holds cash in trust and issues ordinary shares (KVAC), warrants (KVACW), and units; it generates no significant revenue or operations prior to a business combination. In September 2024, the company entered a definitive merger agreement with clinical-stage biotechnology firm Medera Inc., valuing the combined entity at an implied pre-money enterprise value of $622.6 million with up to $149.5 million in cash proceeds from KVACU's trust (subject to redemptions), expected to list Medera on Nasdaq upon closing in the fourth quarter of 2024, though the transaction remains pending shareholder approval and customary conditions as of late 2025; KVACU has since extended its business combination deadline multiple times through unsecured promissory notes to sponsor KVC Sponsor LLC, including $200,000 notes in late 2024 and early 2025, a $145,000 no-interest note in November 2025, and monthly trust deposits reaching November 27, 2025.